Torray LLC Rocket Pharmaceuticals, Inc. Transaction History

Torray LLC

$641 Million
Q1 2025

A detailed history of Torray LLC transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Torray LLC holds 117,301 shares of RCKT stock, worth $324,923. This represents 0.12% of its overall portfolio holdings.

Number of Shares

117,301

Previous 122,095 3.93%

Holding current value

$324,923

Previous $1.53 Million 49.02%

% of portfolio

0.12%

Previous 0.23%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 08, 2025	SELL	$6.67 - $12.72 $31,975 - $60,979	-4,794 Reduced 3.93%	117,301 $782,000
Q4 2024 Feb 06, 2025	BUY	$11.35 - $18.82 $552,415 - $915,988	48,671 Added 66.29%	122,095 $1.53 Million
Q3 2024 Nov 05, 2024	BUY	$17.6 - $25.88 $109,260 - $160,663	6,208 Added 9.24%	73,424 $1.36 Million
Q2 2024 Aug 06, 2024	BUY	$20.66 - $26.72 $129,806 - $167,881	6,283 Added 10.31%	67,216 $1.45 Million
Q1 2024 May 10, 2024	BUY	$26.16 - $30.74 $1.37 Million - $1.61 Million	52,244 Added 601.27%	60,933 $1.64 Million
Q1 2024 May 09, 2024	SELL	$26.16 - $30.74 $1.36 Million - $1.6 Million	-52,167 Reduced 85.72%	8,689 $234,000
Q4 2023 Feb 08, 2024	BUY	$16.78 - $31.94 $11,393 - $21,687	679 Added 1.13%	60,856 $1.82 Million
Q3 2023 Nov 08, 2023	BUY	$15.07 - $24.05 $84,512 - $134,872	5,608 Added 10.28%	60,177 $1.23 Million
Q2 2023 Jul 20, 2023	BUY	$16.59 - $23.6 $5,590 - $7,953	337 Added 0.62%	54,569 $1.08 Million
Q1 2023 May 02, 2023	SELL	$15.79 - $22.6 $1,452 - $2,079	-92 Reduced 0.17%	54,232 $928,000
Q4 2022 Feb 08, 2023	BUY	$15.5 - $22.76 $842,022 - $1.24 Million	54,324 New	54,324 $1.06 Million
Q3 2022 Nov 04, 2022	SELL	$12.37 - $18.41 $43,591 - $64,876	-3,524 Reduced 5.83%	56,951 $909,000
Q2 2022 Aug 03, 2022	BUY	$7.96 - $16.64 $133,887 - $279,884	16,820 Added 38.53%	60,475 $832,000
Q1 2022 May 03, 2022	SELL	$13.16 - $23.68 $479,668 - $863,112	-36,449 Closed	0 $0
Q4 2021 Feb 04, 2022	SELL	$21.52 - $36.02 $28,686 - $48,014	-1,333 Reduced 3.53%	36,449 $796,000
Q3 2021 Nov 02, 2021	BUY	$27.42 - $48.97 $11,571 - $20,665	422 Added 1.13%	37,782 $1.13 Million
Q2 2021 Aug 03, 2021	BUY	$39.41 - $47.25 $327,063 - $392,127	8,299 Added 28.56%	37,360 $1.66 Million
Q1 2021 May 03, 2021	SELL	$43.34 - $65.91 $234,166 - $356,111	-5,403 Reduced 15.68%	29,061 $1.29 Million
Q4 2020 Feb 03, 2021	SELL	$23.3 - $59.57 $333,912 - $853,697	-14,331 Reduced 29.37%	34,464 $1.89 Million
Q3 2020 Nov 02, 2020	BUY	$20.5 - $28.59 $4,469 - $6,232	218 Added 0.45%	48,795 $1.12 Million
Q2 2020 Aug 03, 2020	SELL	$13.32 - $22.61 $104,974 - $178,189	-7,881 Reduced 13.96%	48,577 $1.02 Million
Q1 2020 Apr 28, 2020	BUY	$9.71 - $25.11 $256,344 - $662,904	26,400 Added 87.83%	56,458 $788,000
Q4 2019 Feb 11, 2020	BUY	$11.07 - $24.23 $332,742 - $728,305	30,058 New	30,058 $684,000

Others Institutions Holding RCKT

# of Institutions

258

Shares Held

108M

Call Options Held

555K

Put Options Held

177K

View Full List

About ROCKET PHARMACEUTICALS, INC.

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $210M
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

More about RCKT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Torray LLC, based on Form 13F filings with the SEC.

News

Stay updated on Torray LLC with notifications on news.

Account